Early Evaluation of ctDNA as a Marker of Therapeutic Efficacy and Prognosis in Patients With Breast Cancer During Primary Systemic Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy
Breast 2024 Aug 01;76(xx)103738, R Wang, B Wang, H Zhang, X Liao, B Shi, Y Zhou, C Zhou, Y Yan, W Zhang, K Wang, G Ge, Y Ren, X Tang, B Gan, J He, L NiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.